Pages that link to "Q71092101"
Jump to navigation
Jump to search
The following pages link to Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism (Q71092101):
Displaying 50 items.
- Hyperplasia in glands with hormone excess (Q26786759) (← links)
- Calcium-Sensing Receptor Gene: Regulation of Expression (Q28079054) (← links)
- A Novel Ex Vivo Method for Visualizing Live-Cell Calcium Response Behavior in Intact Human Tumors (Q28553611) (← links)
- Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor function (Q30498366) (← links)
- Lack of FGF23 response to acute changes in serum calcium and PTH in humans (Q33570120) (← links)
- Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease (Q33917786) (← links)
- Primary hyperparathyroidism: pathophysiology and impact on bone (Q33954167) (← links)
- Differential gene expression by oxyphil and chief cells of human parathyroid glands (Q34274874) (← links)
- Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism (Q34362759) (← links)
- Renal osteodystrophy (Q34436411) (← links)
- Molecular mechanisms of primary hyperparathyroidism (Q34437592) (← links)
- Calcium receptor and regulation of parathyroid hormone secretion (Q34437598) (← links)
- Uncoupling of secretion from growth in some hormone secretory tissues (Q34468153) (← links)
- Hyperparathyroid Genes: Sequences Reveal Answers and Questions (Q34628063) (← links)
- Cyclooxygenase 2 Promotes Parathyroid Hyperplasia in ESRD (Q34726849) (← links)
- Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics (Q34795759) (← links)
- Regulator of G Protein Signaling 5 Is Highly Expressed in Parathyroid Tumors and Inhibits Signaling by the Calcium-Sensing Receptor (Q34856298) (← links)
- Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs (Q35026640) (← links)
- Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia (Q35089623) (← links)
- Efficacy of early treatment with calcimimetics in combination with reduced doses of vitamin d sterols in dialysis patients (Q35573639) (← links)
- The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS. (Q35573642) (← links)
- Secondary hyperparathyroidism disease stabilization following calcimimetic therapy (Q35573653) (← links)
- The enigma of hyperparathyroidism in hypophosphatemic rickets (Q35688471) (← links)
- Calcium sensing by endocrine cells (Q36004163) (← links)
- The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport (Q36056698) (← links)
- Regulation of parathyroid function in chronic renal failure. (Q36406660) (← links)
- Single-cell functional analysis of parathyroid adenomas reveals distinct classes of calcium sensing behaviour in primary hyperparathyroidism. (Q36504279) (← links)
- Minimizing bone abnormalities in children with renal failure (Q36561062) (← links)
- Regulation of parathyroid function in chronic kidney disease (CKD). (Q36606963) (← links)
- The kidney and bone metabolism: Nephrologists' point of view. (Q36638034) (← links)
- Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth (Q36938854) (← links)
- Phosphate Toxicity in CKD: The Killer among Us (Q36965142) (← links)
- Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients (Q37095019) (← links)
- Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? (Q37310824) (← links)
- Calcium-sensing receptor in cancer: good cop or bad cop? (Q37326557) (← links)
- Associations of the calcium-sensing receptor gene CASR rs7652589 SNP with nephrolithiasis and secondary hyperparathyroidism in haemodialysis patients. (Q37339940) (← links)
- The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor (Q37376070) (← links)
- Hyperparathyroidism and malnutrition with severe vitamin D deficiency (Q37464895) (← links)
- Novel regulatory aspects of the extracellular Ca2+-sensing receptor, CaR. (Q37502763) (← links)
- Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders (Q37635257) (← links)
- Diseases of the parathyroid gland in chronic kidney disease. (Q37912038) (← links)
- Management of secondary hyperparathyroidism: how and why? (Q38775426) (← links)
- Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies. (Q39220825) (← links)
- Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. (Q39946549) (← links)
- The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism (Q40318220) (← links)
- Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention. (Q40318301) (← links)
- The role of the calcium-sensing receptor in the pathophysiology of secondary hyperparathyroidism (Q40319201) (← links)
- Changes in cytoplasmic calcium determine the secretory response to extracellular cations in human parathyroid cells: a confocal microscopy study using FM1-43 dye (Q40841374) (← links)
- Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. (Q41198044) (← links)
- Vitamin D and its analogs in chronic renal failure (Q41736081) (← links)